Neuraxis, INC (NRXS) stock
NRXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.61−0.19 (-3.96%)
Close on Nov 17, 2026Market cap $57.89MP/E –Yield –
Neuraxis gross margin
Gross margin is gross profit as a percentage of revenue.
Neuraxis's gross margin for the twelve months ending Jun 30, 2026 was 85.6%. For fiscal 2025 it was 84.2%, against 86.5% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 84.2% | −2.3 |
| FY2024 | Dec 31, 2024 | 86.5% | −1.1 |
| FY2023 | Dec 31, 2023 | 87.7% | −1.3 |
| FY2022 | Dec 31, 2022 | 88.9% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 85.9% | +2.3 |
| Q1 FY2026 | Mar 31, 2026 | 86.4% | +2.0 |
| Q4 FY2025 | Dec 31, 2025 | 85.4% | −0.8 |
| Q3 FY2025 | Sep 30, 2025 | 83.3% | −2.1 |
| Q2 FY2025 | Jun 30, 2025 | 83.6% | −4.4 |
| Q1 FY2025 | Mar 31, 2025 | 84.4% | −4.0 |
| Q4 FY2024 | Dec 31, 2024 | 86.2% | −0.2 |
| Q3 FY2024 | Sep 30, 2024 | 85.4% | −0.5 |
| Q2 FY2024 | Jun 30, 2024 | 88.0% | −1.5 |
| Q1 FY2024 | Mar 31, 2024 | 88.4% | +0.3 |
| Q4 FY2023 | Dec 31, 2023 | 86.4% | −1.3 |
| Q3 FY2023 | Sep 30, 2023 | 85.9% | −3.2 |
| Q2 FY2023 | Jun 30, 2023 | 89.5% | +1.1 |
| Q1 FY2023 | Mar 31, 2023 | 88.1% | – |
| Q4 FY2022 | Dec 31, 2022 | 87.7% | – |
| Q3 FY2022 | Sep 30, 2022 | 89.1% | – |
| Q2 FY2022 | Jun 30, 2022 | 88.4% | – |
See a number that looks wrong?